Factors associated with reduced adherence to antihypertensive drug treatment (AHT) were identified analysing 7626 Italian patients with blood pressure values recorded in the General Practitioners database. About 25% of patients taking antihypertensive drugs were not adherent to treatment; factors associated with poor adherence were younger age and female gender of patient, recent start of AHT, absence of diabetes, absence of chronic renal insufficiency and absence of concomitant drug treatments. Only 48% of patients taking antihypertensive drugs achieved blood pressure levelso140/90 mm Hg: this percentage was 44% in patients who presented with diabetes or chronic renal insufficiency and 55% in those with previous cardiovascular events.
Numerous clinical trials have clearly demonstrated how the correct antihypertensive drug treatment (AHT) significantly reduces cardiovascular diseases and mortality. [1] [2] [3] In clinical practice, however, the use of antihypertensive drugs is often inadequate in terms of the numbers of patients treated and in terms of treatment adherence. [4] [5] [6] [7] This means that blood pressure (BP) values are not controlled sufficiently by drug treatment. 8 Fifty general practitioners in the Ravenna area, Italy, voluntarily participated in the PANDORA project, a prospective on-going global outcomes study begun in 1996 to organize an electronic database to be used in pharmaco-epidemiological evaluations aimed at improving clinical practice. 9 The study was approved by the Local Ethics Committee and each patient enrolled gave informed consent. The data examined included all the patientsX18 years, treated with antihypertensive drugs, with at least one BP reading during the enrolment period, defined as from 1 January 2003 to 31 December 2004. The follow-up period was defined retrospectively and consisted of the 12 months before the most recent BP measurement. The antihypertensive drugs prescribed to each patient were identified from the General Practitioner database, records of any hospitalizations were derived from the hospital database kept by the Local Health Unit of Ravenna.
Subjects who had not been prescribed any antihypertensive drugs during the 12 months before the follow-up period were defined as recently treated patients. AHT adherence was measured by calculating the proportion of days covered by treatment, obtained with the following formula: days of treatment coverage/days elapsing between first prescription of antihypertensive drugs in the retrospective follow-up and the most recent BP measurement. Treatment coverage was calculated by dividing the quantity of drug contained in the individual prescriptions by the defined daily dose (DDD). 10 The patients who presented a proportion of days covered by treatment lower than 0.75 and the patients who had interrupted drug treatment in the last 3 months of follow-up were defined as not adherent to treatment.
Continuous variables are presented as mean values7s. d. A multivariable logistic regression model was developed to identify factors associated with poor adherence to the AHT adjusting for potential external influences. Only the statistically significant (P-values less than 0.05) relative risks of poor adherence are reported.
Overall, 7626 patients were taking antihypertensive drugs (3222 male subjects, 4404 female subjects, mean age: 67.5711.8). Among these patients, 1947 subjects (25.5%) presented a proportion of covered days of less than 0.75 or had suspended drug treatment in the last 3 months of observation. The logistic regression model (Table 1) identified seven independent factors indicating poor adherence to drug treatment: youth of the patients (Po0.001), female gender (Po0.001), recent start of AHT (Po0.001), absence of diabetes (Po0.001), absence of chronic renal insufficiency (Po0.05) and absence of concomitant drug treatments (lipidlowering Po0.001, platelet inhibitors Po0.001).
In general, 3959 subjects (51.9%) at the end of the observation period, presented BP valuesX140/ 90 mm Hg. These subjects, compared to patients with BPo140/90 mm Hg, were older (mean age: 68.6711.6 versus 66.3711.9 years), included a higher proportion of diabetic patients (10 Factors associated with poor adherence highlight how the probability of taking drugs in an inadequate manner is higher in patients without other cardiovascular risk factors and that presented, as a whole, a more favourable clinical condition. Subjects without other cardiovascular risk factors, less aware of being at risk, are less sensitive to the importance of treatment and less willing to follow a correct therapeutic regimen. In the same way, patients with no other concomitant therapies are not only less used to following systematically pharmacological treatment but they also present a less complex clinical situation and are less aware of the benefits of AHT. Moreover, the probability of poor adherence to treatment is higher among newly treated patients, subjects who are not used to regular drug treatment regimes in whom there are more frequent observations of side effects of a therapy that is not yet fully tailored to the patient's individual needs. Appropriate recognition of these factors is expected to result in an improved doctor-patient relationship and in a better control of blood pressure.
In this setting, a useful means of applying the results of this study to daily clinical practice could be the computerized prescribing applications, which has been shown to reduce medication error rates. 11 This type of solution, at present used almost exclusively to prevent adverse drugs events, could in fact be extended to wider settings to signal the categories of patients in which it is necessary to insist on the importance of a correct therapeutic regimen. Although the predictors identified in this study should be validated in other settings, they can easily be preset to clinicians using computerized prescribing applications. Such a system would make it easy for physicians to consider these predictors in their daily practice.
The analysis of patients treated with antihypertensive drugs revealed another aspect: at the end of the follow-up, a relevant percentage of subjects (51.9%) did not adequately control their BP values. This unsatisfactory control was also present in the high-risk patients: only 20.2% of patients who presented with diabetes or chronic renal insufficiency achieved values of less than 130/80 mm Hg, as recommended by the Joint National Committee VII guidelines. 12 This fact highlights the need to implement training programs for General Practitioners with the aim of reaching a more careful pursuance of the therapeutic objective, especially in subjects with a high cardiovascular risk.
Some considerations can also be made concerning the limits of this study. In the first place, the results come from a single geographic area in Italy. The findings, however, are in line with the results of other studies carried out in other parts of Italy, 13 and contribute to a more detailed picture of the Italian situation. In the second place, our pharmaceutical database does not contain information on the prescribed daily doses (PDDs); therefore, adherence to drug treatment was estimated on the basis of the DDDs, which is, nonetheless, a useful instrument for comparing the results from different studies. 10 A strong point of the study is, on the contrary, the joint use of the hospital database kept by the Local Health Unit and the general practitioner archives. This integration made it possible to analyse, in the context of real clinical practice, the pharmacological management of hypertension in patients with different cardiovascular risk profiles. What is known about the topic K Several surveys have shown how the correct antihypertensive drug treatment significantly reduces cardiovascular diseases and mortality. K In clinical practice, the use of antihypertensive drugs is definitely inconsistent with the objectives set by guidelines, both in terms of treatment adherence and in terms of blood pressure control.
What this study adds K Our study identified seven independent factors indicating poor adherence to drug treatment: youth of the patients, female gender, recent start of antihypertensive treatment, absence of diabetes, absence of chronic renal insufficiency and absence of concomitant drug treatments (lipid-lowering, platelet inhibitors). K Although the predictors identified in this study should be validated in other settings, they can easily be preset to clinicians using computerized prescribing applications. Such a system would make it easy for physicians to consider these predictors in their daily practice.
